MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 186 filers reported holding MYRIAD GENETICS INC in Q2 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $216,877 | -64.3% | 13,521 | -48.3% | 0.00% | -100.0% |
| Q1 2023 | $607,441 | +7.0% | 26,149 | -33.2% | 0.01% | -10.0% |
| Q4 2022 | $567,718 | +40.2% | 39,126 | +84.2% | 0.01% | +25.0% |
| Q3 2022 | $405,000 | +1.5% | 21,246 | +34.0% | 0.01% | -27.3% |
| Q1 2022 | $399,000 | +67.6% | 15,852 | +114.8% | 0.01% | +57.1% |
| Q3 2021 | $238,000 | -60.4% | 7,381 | -84.0% | 0.01% | -89.6% |
| Q3 2020 | $601,000 | +142.3% | 46,114 | +111.3% | 0.07% | +21.8% |
| Q2 2020 | $248,000 | -30.7% | 21,826 | -12.6% | 0.06% | -30.4% |
| Q1 2020 | $358,000 | +59.1% | 24,980 | +202.5% | 0.08% | +464.3% |
| Q4 2019 | $225,000 | -77.8% | 8,258 | -76.7% | 0.01% | -76.7% |
| Q3 2019 | $1,013,000 | +126.1% | 35,400 | +162.2% | 0.06% | -18.9% |
| Q1 2019 | $448,000 | – | 13,500 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |